THLD Insider Trading Activity and SEC Form 4 Filings
THLD insider trading summary
No open-market insider purchases or sales of Threshold Pharmaceuticals Inc (THLD) have been reported on SEC Form 4 in the past 12 months.
Latest THLD insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 1, 2017 | Jeffrey W Bird | Director | Buy | $268K (473,077 @ $0.57) |
| Jun 1, 2017 | Jeffrey W Bird | Director | Buy | $21K (37,626 @ $0.57) |
| Sep 28, 2015 | Joel A Fernandes | Senior Vice President | Buy | $14K (3,562 @ $3.96) |
| Feb 18, 2015 | Wilfred E Jaeger | Director | Buy | $94K (25,000 @ $3.75) |
| Oct 13, 2014 | Nipun Davar | Vice President | Buy | $9K (3,000 @ $2.98) |
| Oct 1, 2014 | James N White | 10% Owner | Sell | $49K (12,881 @ $3.77) |
| Oct 1, 2014 | Stefan A Dyckerhoff | 10% Owner | Sell | $855K (226,657 @ $3.77) |
| Oct 1, 2014 | James C Gaither | 10% Owner | Sell | $855K (226,657 @ $3.77) |
| Oct 1, 2014 | William H Younger Jr | 10% Owner | Sell | $855K (226,657 @ $3.77) |
| Oct 1, 2014 | G Leonard Baker Jr | 10% Owner | Sell | $14K (3,791 @ $3.77) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.